← Directory

iPredict-DR

iHealthScreen

FDA cleareddiabetic retinopathydiabetes screening

AI software that screens color fundus images for more-than-mild diabetic retinopathy in adults with diabetes. FDA cleared in mid-2026; the company's AMD and glaucoma modules are not yet FDA cleared.

Company
iHealthScreen
Category
Screening
Reads
Color fundus photographs (iCare DRSplus camera named in iCare/Revenio announcement)
Built for
Primary care and eye clinics screening adults with diabetes
Billing
Check vendor
Regulatory
FDA 510(k) K253704, decision Jul 2, 2026, product code PIB. Company also reports CE and MHRA registration for its DR/AMD/glaucoma tools (not independently verified); an AMD 510(k) was reported as submitted, not cleared. · source
Last verified
2026-10-07

DotAEye is independent of iHealthScreen. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.